These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27585955)

  • 1. 3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
    Piotrowska-Kempisty H; Ruciński M; Borys S; Kucińska M; Kaczmarek M; Zawierucha P; Wierzchowski M; Łażewski D; Murias M; Jodynis-Liebert J
    Sci Rep; 2016 Sep; 6():32627. PubMed ID: 27585955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer.
    Piotrowska H; Myszkowski K; Abraszek J; Kwiatkowska-Borowczyk E; Amarowicz R; Murias M; Wierzchowski M; Jodynis-Liebert J
    Biomed Pharmacother; 2014 May; 68(4):397-400. PubMed ID: 24768110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
    Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J
    Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3,4,5,4'-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells.
    Piotrowska-Kempisty H; Klupczyńska A; Trzybulska D; Kulcenty K; Sulej-Suchomska AM; Kucińska M; Mikstacka R; Wierzchowski M; Murias M; Baer-Dubowska W; Kokot Z; Jodynis-Liebert J
    Toxicol Lett; 2017 Feb; 267():59-66. PubMed ID: 28049037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells.
    Nowicki A; Skupin-Mrugalska P; Jozkowiak M; Wierzchowski M; Rucinski M; Ramlau P; Krajka-Kuzniak V; Jodynis-Liebert J; Piotrowska-Kempisty H
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.
    Piotrowska H; Myszkowski K; Amarowicz R; Murias M; Kulcenty K; Wierzchowski M; Jodynis-Liebert J
    Toxicol In Vitro; 2013 Dec; 27(8):2127-34. PubMed ID: 24055891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of 4'-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines.
    Jozkowiak M; Skupin-Mrugalska P; Nowicki A; Borys-Wojcik S; Wierzchowski M; Kaczmarek M; Ramlau P; Jodynis-Liebert J; Piotrowska-Kempisty H
    Nutrients; 2020 May; 12(5):. PubMed ID: 32392733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model.
    Nowicki A; Wawrzyniak D; Czajkowski M; Józkowiak M; Pawlak M; Wierzchowski M; Rolle K; Skupin-Mrugalska P; Piotrowska-Kempisty H
    Drug Deliv; 2022 Dec; 29(1):2459-2468. PubMed ID: 35892260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
    Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency.
    Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA
    Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis.
    Piotrowska H; Kujawska M; Nowicki M; Petzke E; Ignatowicz E; Krajka-Kuźniak V; Zawierucha P; Wierzchowski M; Murias M; Jodynis-Liebert J
    Hum Exp Toxicol; 2017 Feb; 36(2):160-175. PubMed ID: 27048571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
    Tan L; Wang W; He G; Kuick RD; Gossner G; Kueck AS; Wahl H; Opipari AW; Liu JR
    Cancer; 2016 Mar; 122(5):722-9. PubMed ID: 26619367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.
    Sale S; Verschoyle RD; Boocock D; Jones DJ; Wilsher N; Ruparelia KC; Potter GA; Farmer PB; Steward WP; Gescher AJ
    Br J Cancer; 2004 Feb; 90(3):736-44. PubMed ID: 14760392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of HPLC-MS/MS procedure for determination of 3,4,4',5-tetra-methoxystilbene (DMU-212) and its metabolites in ovarian cancer cells and culture medium.
    Klupczynska A; Sulej-Suchomska AM; Piotrowska-Kempisty H; Wierzchowski M; Jodynis-Liebert J; Kokot ZJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():30-35. PubMed ID: 28582662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin synergizes with resveratrol to inhibit colon cancer.
    Majumdar AP; Banerjee S; Nautiyal J; Patel BB; Patel V; Du J; Yu Y; Elliott AA; Levi E; Sarkar FH
    Nutr Cancer; 2009; 61(4):544-53. PubMed ID: 19838927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
    Stuckey A; Fischer A; Miller DH; Hillenmeyer S; Kim KK; Ritz A; Singh RK; Raphael BJ; Brard L; Brodsky AS
    BMC Cancer; 2011 Jul; 11():308. PubMed ID: 21781307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.
    Penthala NR; Thakkar S; Crooks PA
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2763-7. PubMed ID: 26022840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition.
    Jozkowiak M; Dyszkiewicz-Konwinska M; Ramlau P; Kranc W; Spaczynska J; Wierzchowski M; Kaczmarek M; Jodynis-Liebert J; Piotrowska-Kempisty H
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
    Sale S; Tunstall RG; Ruparelia KC; Potter GA; Steward WP; Gescher AJ
    Int J Cancer; 2005 Jun; 115(2):194-201. PubMed ID: 15688382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of DMU-212-induced apoptosis and anti-angiogenesis in vascular endothelial cells.
    Miao Y; Cui L; Chen Z; Zhang L
    Pharm Biol; 2016; 54(4):660-6. PubMed ID: 26428916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.